Role of adhesion molecules in bladder cancer: An important part of the jigsaw

Urology

Volumn 53, Issue 2, 1999, Pages 428-434

  Syrigos, Konstantinos N ^a   Harrington, K J ^a   Pignatelli, M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CADHERIN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN; INTEGRIN; MEMBRANE PROTEIN; SELECTIN;

ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MOTILITY; DESQUAMATION; EXTRACELLULAR MATRIX; HUMAN; LAMINA PROPRIA; METASTASIS; MOLECULAR INTERACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 0032928111     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00527-5     Document Type: Review

References (56)

1. Parker S.L., Tong T., Bolden S., et al. Cancer statistics, 1997. CA Cancer J Clin. 47:1997;5-17.
2. Albelda S.M. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest. 68:1993;4-17.
3. Takeichi M. Cadherins in cancer implications for invasion and metastasis . Curr Opin Cell Biol. 5:1993;806-811.
4. Jezernik K. Desquamation of urinary bladder epithelial cells. Pflugers Arch. 431:1996;249-250.
5. Tuckwell D.S., Weston S.A., Humphries M.J. Integrins a review of their structure and mechanisms of ligand binding . Symp Soc Exp Biol. 47:1993;107-136.
6. Edelman G.M., Crossin K.L. Cell adhesion molecules implications for a molecular histology . Annu Rev Biochem. 60:1991;155-190.
7. Hynes R.O., Lander A.D. Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell. 68:1992;303-322.
8. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 251:1991;1451-1455.
9. Duband J.L., Dufour S., Hatta K., et al. Adhesion molecules during somitogenesis in the avian embryo. J Cell Biol. 104:1987;1361-1374.
10. Behrens J., Frixen U., Schipper J., et al. Cell adhesion in invasion and metastasis. Semin Cell Biol. 3:1992;169-178.
11. Ozawa M., Kemler R. Molecular organization of the uvomorulin-catenin complex. J Cell Biol. 116:1992;989-996.
12. Shibamoto S., Hayakawa M., Takeuchi K., et al. Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun. 1:1994;295-305.
13. Hirano S., Kimoto N., Shimoyama Y., et al. Identification of a neural alpha-catenin as a key regulator of cadherin function and multicellular organization. Cell. 70:1992;293-301.
14. Knudsen K.A., Wheelock M.J. Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin. J Cell Biol. 118:1992;671-679.
15. Ozawa M., Nuruki K., Toyoyama H., et al. Cloning of an alternative form of plakoglobin (gamma-catenin) lacking the fourth armadillo repeat. J Biochem Tokyo. 118:1995;836-840.
16. Su L.K., Vogelstein B., Kinzler K.W. Association of the APC tumor suppressor protein with catenins. Science. 262:1993;1734-1737.
17. Tsao J., Shibata D. Further evidence that one of the earliest alterations in colorectal carcinogenesis involves APC. Am J Pathol. 145:1994;531-534.
18. Munemitsu S., Albert I., Rubinfeld B., et al. Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol Cell Biol. 16:1996;4088-4094.
19. Midgley C.A., White S., Howitt R., et al. APC expression in normal human tissues. J Pathol. 181:1997;426-433.
20. Hulsken J., Birchmeier W., Behrens J. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol. 127:1994;2061-2069.
21. Rubinfeld B., Souza B., Albert I., et al. The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin. J Biol Chem. 270:1995;5549-5555.
22. Behrens J., Mareel M.M., Van-Roy F.M., et al. Dissecting tumor cell invasion epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion . J Cell Biol. 108:1989;2435-2447.
23. Frixen U.H., Behrens J., Sachs M., et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 113:1991;173-185.
24. Fujisawa M., Miyazaki J., Takechi Y., et al. The significance of E-cadherin in transitional-cell carcinoma of the human urinary bladder. World J Urol. 14:1996;S12-S15.
25. Ross J.S., del-Rosario A.D., Bui H.X., et al. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma. Mod Pathol. 9:1996;854-860.
26. Syrigos K.N., Krausz T., Waxman J., et al. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues correlation with histopathological grade, tumour stage and survival . Int J Cancer. 64:1995;367-370.
27. Lipponen P.K., Eskelinen M.J. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J Cancer Res Clin Oncol. 121:1995;303-308.
28. Shimazui T., Schalken J.A., Giroldi L.A., et al. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. Cancer Res. 56:1996;4154-4158.
29. Griffiths T.R., Brotherick I., Bishop R.I., et al. Cell adhesion molecules in bladder cancer soluble serum E-cadherin correlates with predictors of recurrence . Br J Cancer. 74:1996;579-584.
30. Banks R.E., Porter W.H., Whelan P., et al. Soluble forms of the adhesion molecule E-cadherin in urine. J Clin Pathol. 48:1995;179-180.
31. Tsuda H., Zhang W.D., Shimosato Y., et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1990;6791-6794.
32. Katayama M., Hirai S., Kamihagi K., et al. Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer. 69:1994;580-585.
33. Shiozaki H., Oka H., Inoue M., et al. E-cadherin mediated adhesion system in cancer cells. Cancer. 77:1996;1605-1613.
34. Hynes R.O. The impact of molecular biology on models for cell adhesion. Bioessays. 16:1994;663-669.
35. Sonnenberg A., Linders C.J., Modderman P.W., et al. Integrin recognition of different cell-binding fragments of laminin (P1, E3, E8) and evidence that alpha 6 beta 1 but not alpha 6 beta 4 functions as a major receptor for fragment E8. J Cell Biol. 110:1990;2145-2155.
36. Elices M.J., Osborn L., Takada Y., et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:1990;577-584.
37. Humphries M.J., Olden K., Yamada K.M. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science. 233:1986;467-470.
38. Isoai A., Ueno Y., Giga-Hama Y., et al. A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis a possible mechanism of RGD peptide-mediated inhibition of tumor metastasis . Cancer Lett. 65:1992;259-264.
39. Wilson C.B., Leopard J., Cheresh D.A., et al. Extracellular matrix and integrin composition of the normal bladder wall. World J Urol. 14:1996;S30-S37.
40. Grossman H.B., Washington R.W. Jr, Carey T.E., et al. Alterations in antigen expression in superficial bladder cancer. J Cell Biochem Suppl. 161:1992;63-68.
41. Liebert M., Washington R., Wedemeyer G., et al. Loss of co-localization of alpha 6 beta 4 integrin and collagen VII in bladder cancer. Am J Pathol. 144:1994;787-795.
42. Liebert M., Washington R., Stein J., et al. Expression of the VLA beta 1 integrin family in bladder cancer. Am J Pathol. 144:1994;1016-1022.
43. Hunkapiller T., Hood L. Diversity of the immunoglobulin gene superfamily. Adv Immunol. 44:1989;1-63.
44. Jackson A.M., Alexandroff A.B., McIntyre M., et al. Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy. J Clin Pathol. 47:1994;309-312.
45. Nouri A.M., Hussain R.F., Dos-Santos A.V., et al. Defective expression of adhesion molecules on human bladder tumour and human tumour cell lines. Urol Int. 56:1996;6-12.
46. Campbell S.C., Tanabe K., Alexander J.P., et al. Intercellular adhesion molecule-1 expression by bladder cancer cells functional effects . J Urol. 151:1994;1385-1390.
47. Brewster S.F., Gingell J.C., Browne S., et al. Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer. 70:1994;697-700.
48. Miyamoto H., Shuin T., Ikeda I., et al. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer. J Urol. 155:1996;1444-1447.
49. Takashi M., Murase T., Mitsuya H., et al. Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer. Hinyokika Kiyo. 32:1986;541-552.
50. Casetta G., Cavallini A., Piana P., et al. Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder. Minerva Urol Nefrol. 44:1992;169-172.
51. Wolf H. Prognostic factors in bladder carcinoma. Scand J Urol Nephrol. 138:1991;153-160.
52. Jakse G., Rauschmeier H., Rosmanith P., et al. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder. Urol Int. 38:1983;121-125.
53. Vogel J., Oehr P., Maisey R., et al. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder. Cancer Detect Prev. 11:1988;389-396.
54. Bevilacqua M., Butcher E., Furie B., et al. Selectins a family of adhesion receptors . Cell. 67:1991;233-237.
55. Huttenlocher A., Sandborg R.R., Horwitz A.F. Adhesion in cell migration. Curr Opin Cell Biol. 7:1995;697-706.
56. Frenette P.S., Wagner D.D. Molecular medicine adhesion molecules . N Engl J Med. 334:1996;1526-1529.